Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience
Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience is a paper indexed in PICO Portal from OpenAlex.
How many citations does Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience have?
Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience has 36 citations in the OpenAlex counts PICO Portal stores.
When was Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience published?
Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience has 2019 year in the PICO Portal index.
What is the open-access status of Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience?
Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience has green oa status in the PICO Portal index.
What is the DOI of Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience?
The DOI for Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience is on the source record.
What is the PMID of Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience?
The PMID for Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience is on the source record.
What is the OpenAlex record for Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience?
The OpenAlex for Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience is on the source record.